Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis

Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis

Bibliographic Details
Main Authors:	Guangtong Deng, Qian Zhou, Yu Meng, Huiyan Sun, Songtao Du, Yihuang Liu, Furong Zeng
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Series:	MedComm
Online Access:	https://doi.org/10.1002/mco2.307

Similar Items

Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients
by: Yihuang Liu, et al.
Published: (2023-11-01)

Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
by: Qian Zhou, et al.
Published: (2023-06-01)

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
by: Qian Zhou, et al.
Published: (2023-04-01)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
by: Songtao Du, et al.
Published: (2023-02-01)

Immunocompromised individuals are at increased risk of COVID‐19 breakthrough infection, hospitalization, and death in the post‐vaccination era: A systematic review
by: Bytyci, J, et al.
Published: (2024)

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
by: Qian Zhou, et al.
Published: (2024-03-01)

Vaccination of Immunocompromised Cats
by: Katrin Hartmann, et al.
Published: (2022-04-01)

Vaccination in Immunocompromised Patients
by: Ashwin Mathur; Hemant Malhotra
Published: (2023-10-01)

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
by: Songtao Du, et al.
Published: (2022-02-01)

Breakthrough infections in MPN-COVID vaccinated patients
by: Tiziano Barbui, et al.
Published: (2022-11-01)

Profile of Brazilian inpatients with COVID-19 vaccine breakthrough infection and risk factors for unfavorable outcome
by: Matheus A. S. de Jesus, et al.
Published: (2022-08-01)

HPV vaccination of immunocompromised hosts
by: S.M. Garland, et al.
Published: (2017-12-01)

SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
by: Xiaohui Jing, et al.
Published: (2023-09-01)

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
by: Furong Zeng, et al.
Published: (2023-02-01)

Pneumococcal Vaccination in Immunocompromised Hosts: An Update
by: Claire Froneman, et al.
Published: (2021-05-01)

Seasonal influenza vaccine in immunocompromised persons
by: Mohammad Bosaeed, et al.
Published: (2018-06-01)

Infections by protozoa in immunocompromised hosts
by: Marcelo Simão Ferreira
Published: (2000-01-01)

Fungal infections in the immunocompromised host
by: Bodo Wanke, et al.
Published: (2000-01-01)

Correction: SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
by: Xiaohui Jing, et al.
Published: (2023-10-01)

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
by: Furong Zeng, et al.
Published: (2022-11-01)

Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis
by: Ze-Dong Wang, et al.
Published: (2017-03-01)

Why do breakthrough COVID-19 infections occur in the vaccinated?
by: Maclean, P, et al.
Published: (2021)

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel
by: Naama Yekutiel, et al.
Published: (2023-02-01)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
by: Xiaojing Zhang, et al.
Published: (2022-11-01)

Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
by: Ka-Li Zhu, et al.
Published: (2023-02-01)

Vaccines and therapeutics for immunocompromised patients with COVID-19
by: Shmuel Shoham, et al.
Published: (2023-05-01)

Efficacy of pneumococcal vaccine in immunocompetent and immunocompromised patients
by: M. P. Kostinov, et al.
Published: (2019-11-01)

Nocardia infection of the mastoid in an immunocompromised patient.
by: Subha, Sethu Thakachy, et al.
Published: (2004)

Invasive aspergillosis infection in an immunocompromised patient
by: Elif Gündoğdu, et al.
Published: (2024-02-01)

Disseminated Fusarium infection in an immunocompromised patient Successful outcome with combined antifungal therapy
by: P.G.R.U.M. Welagedara, et al.
Published: (2022-07-01)

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
by: Xiaomeng He, et al.
Published: (2023-06-01)

Risk Factors and Outcomes for Multidrug Resistant <i>Pseudomonas aeruginosa</i> Infection in Immunocompromised Patients
by: Pilar Hernández-Jiménez, et al.
Published: (2022-10-01)

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01)

Prevalence and characteristics of COVID-19 vaccine breakthrough infection in Upper Egypt
by: Aliae A. R. Mohamed Hussein, et al.
Published: (2023-04-01)

Post-vaccination serum cytokines levels correlate with breakthrough influenza infections
by: Weichun Tang, et al.
Published: (2023-01-01)

COVID-19 breakthrough infections in rheumatic diseases patients after vaccination
by: Abeer N. Alshukairi, et al.
Published: (2022-06-01)

COVID–19 breakthrough infection after four doses of the vaccines: A case report
by: Hongrang Zhou, et al.
Published: (2023-01-01)

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases
by: Tobias Alexander, et al.
Published: (2023-04-01)

Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study
by: Xiaomin Wang, et al.
Published: (2023-12-01)

Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity
by: Christina Bahrs, et al.
Published: (2022-05-01)